Phenoxathin derivatives as inhibitors of monoamine oxidase
US6110961A · kind A · utility
4Cited by
5References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 1999 |
| Grant date | Aug 29, 2000 |
| Priority date | — |
| Expiry date | Mar 11, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provide phenoxathiin compounds useful in the prophylaxis and treatment of mental disorders, such as depression. The present invention also provides a method for treating a mammal having depression, anxiety or other conditions responsive to inhibition of MAO-A. A method of preparing the compounds of the present invention is also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.